Genetic abnormalities within the cancerous part of NAFLD-related liver have been reported previously by Kim et al. A mutation in the TERT promoter was found in 82% of the cases with NAFLD-related liver cancer, and chromosome 8p deletion was observed in all cases [14]. This evidence concerns the gene TERT and metabolic dysfunction-associated steatotic liver disease.